Cancer Letters
Volume 201, Issue 1 , Pages 41-49 , 10 November 2003

Modified arabinoxylan rice bran (MGN-3/Biobran) sensitizes human T cell leukemia cells to death receptor (CD95)-induced apoptosis

  • Mamdooh Ghoneum

      Affiliations

    • Department of Otolaryngology, Drew University of Medicine and Science, 1621 E. 120th Street, Los Angeles, CA 90059, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-323-563-5953; fax: +1-310-474-6724
  • ,
  • Sastry Gollapudi

      Affiliations

    • University California Irvine, Division of Basic and Clinical Immunology, Irvine, CA 92697, USA

Received 10 February 2003 ,Revised 10 June 2003 ,Accepted 23 June 2003.

References 

  1. Ghoneum M. Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran. Biochem. Biophys. Res. Commun. 1998;243:25–29
  2. Ghoneum M. Enhancement of human natural killer cell activity by modified arabinoxylane from rice bran (MGN-3). Int. J. Immunother. 1998;XIV:89–99
  3. Ghoneum M, Namatalla G. NK immunomodulatory function in 27 cancer patients by MGN-3, a modified arabinoxylane from rice bran. Abstract, Proceedings of the 87th Annual Meeting of American Association for Cancer Research, Washington, DC, April 20–24. 1996;
  4. Ghoneum M, Brown J. NK immunorestoration of cancer patients by MGN-3, a modified arabinoxylan rice bran (study of 32 patients followed for up to 4 years). In:  Klatz R,  Goldman R editor. Anti-aging Medical Therapeutics. vol. III:Marina del Rey, CA: Health Quest Publications; 1999;p. 217–226
  5. Ghoneum M, Jewett A. Production of tumor necrosis factor-α and interferon-γ from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Cancer Detect. Prev. 2000;24:314–324
  6. Ghoneum M, Tachiki K, Uyemura K, Makinodan T, Makhijani N, Yamaguchi D. Natural biological response modifier (MGN-3) shown to be effective against tumor cell growth. Eighth Int. Congress on Anti-aging Med and Biomedical Technologies, Las Vegas, NV, December 14–l17. 2000;
  7. Jacoby HI, Wnorowski G, Sakata K, Maeda H. The effect of MGN-3 on cisplatin and doxorubicin induced toxicity in the rat. J. Nutraceuticals Funct. Med. Foods. 2001;3:3–11
  8. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a biological phenomena with wide-ranging implications in tissue kinetics. Brit. J. Cancer. 1972;26:239–257
  9. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Rev. Exp. Pathol. Int. 1991;32:223–254
  10. Gupta S. Molecular steps of Tumor necrosis factor receptor-mediated apoptosis. Curr. Mol. Med. 2001;1:299–306
  11. Gupta S. Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci. 2001;69:2957–2964
  12. Green DR, Reed J. Mitochondria and apoptosis. Science. 1998;281:1309–1312
  13. Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv. Immunol. 1994;57:129–134
  14. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281:1305–1308
  15. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995;81:505–512
  16. Cohen GM. Caspases: the executioners of apoptosis. Biochem. J. 1997;32:1–16
  17. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 1999;11:255–260
  18. Dirks W, Schone S, Uphoffo C, Quentmeier H, Pradella S, Drexler HG. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines. Br. J. Haematol. 1997;96:584–593
  19. Darzynkiewicz Z, Li X, Gong J, Traganos F. Methods of apoptosis by flow cytometry. In:  Rose NR,  Foldsand JD,  Najkamura RM editor. Manual of Clinical Laboratory Immunology. Washington, DC: ASM Press; 1997;p. 334–343
  20. Susin SA, ZamZami N, Castedo M, Daugas E, Wang H, Geley S, et al. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO 1/CD95 and ceramide induced apoptosis. J. Exp. Med. 1997;186:25–35
  21. Banki K, Hutter E, Gonchoroff NJ, Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J. Immunol. 1999;162:1466–1479
  22. Nunez G, Clarke MF. The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell. Biol. 1994;4:399–403
  23. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322–1326
  24. Fan H, Morioka T, Ito E. Induction of apoptosis and growth inhibition of cultured human endometrial adenocarcinoma cells (Sawano) by an antitumor lipoprotein fraction of rice bran. Gynecol. Oncol. 2000;76:170–175
  25. Miyoshi N, Koyama Y, Katsuno Y, Hayakawa S, Mita T, Ohta T, et al. Apoptosis induction associated with cell cycle dysregulation by rice bran agglutinin. J. Biochem. (Tokyo). 2001;130:799–805
  26. Han B, Toyomasu T, Shinozawa T. Induction of apoptosis by Coprinus disseminatus mycelial culture broth extract in human cervical carcinoma cells. Cell Struct. Funct. 1999;24:209–215
  27. Sigounas G, Anagnostou A, Steiner M. dl-α-Tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr. Cancer. 1997;28:30–35
  28. Halicka D, Ardelt B, Juan G, Mittelman A, Chen S, Traganos F, et al. Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC SPES. Int. J. Oncol. 1997;11:437–448
  29. Aggarwal S, Gollapudi S, Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J. Immunol. 1999;162:2154–2161
  30. Varela N, Munoz-Pinedo C, Ruiz-Ruiz C, Robeldo G, Pedroso M, Lopez-Rivas A. Interferon-gamma sensitizes human myeloid leukemia cells to death-receptor mediated apoptosis by a pleiotropic mechanism. J. Biol. Chem. 2001;276:1779–1787

PII: S0304-3835(03)00458-0

doi: 10.1016/S0304-3835(03)00458-0

Cancer Letters
Volume 201, Issue 1 , Pages 41-49 , 10 November 2003